Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES Gains 4%; BSE HEALTHCARE Index Down 0.6%
Mon, 9 Sep 9:35

GLENMARK LIFE SCIENCES Gains 4%; BSE HEALTHCARE Index Down 0.6%Image source: StarLineArts/www.istockphoto.com

GLENMARK LIFE SCIENCES share price has zoomed 4% and is presently trading at Rs 1,195.3.

Meanwhile, the BSE HEALTHCARE index is at 43,216.4 (down 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 3.7%) and HIKAL CHEMIC (up 2.2%).

GRANULES INDIA (down 3.5%) and AJANTA PHARMA (down 2.5%) are among the top losers today.

Over the last one year, GLENMARK LIFE SCIENCES has moved up from Rs 632.6 to Rs 1,195.3, registering a gain of Rs 562.7 (up 88.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,216.4, registering a gain of 53.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 139.1%), Glenmark Pharma (up 115.6%) and GRANULES INDIA (up 113.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,914.4 (down 0.3%).

The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 2.1%) and Tata Steel (down 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,755.7 (down 0.4%). ONGC and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 80,914.4, registering a gain of 15,134.1 points (up 23.0%).

GLENMARK LIFE SCIENCES Financial Update...

GLENMARK LIFE SCIENCES net profit fell 17.7% YoY to Rs 1,115 million for the quarter ended June 2024, compared to a profit of Rs 1,355 million a year ago. Net sales rose 1.8% to Rs 5,886 million during the period as against Rs 5,785 million in April-June 2023.

For the year ended March 2024, GLENMARK LIFE SCIENCES reported 0.8% increase in net profit to Rs 4,709 million compared to net profit of Rs 4,670 million during FY23. Revenue of the company grew 5.6% to Rs 22,832 million during FY24.

The current Price to earnings ratio of GLENMARK LIFE SCIENCES, based on rolling 12 month earnings, stands at 32.8.


Equitymaster requests your view! Post a comment on "GLENMARK LIFE SCIENCES Gains 4%; BSE HEALTHCARE Index Down 0.6%". Click here!